missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Human Parkin Antibody, R&D Systems™

Mouse Monoclonal Antibody
209.00 € - 491.00 €
Specifications
| Antigen | Parkin |
|---|---|
| Clone | 328110 |
| Dilution | Immunohistochemistry 5-25 ug/mL |
| Applications | Immunohistochemistry |
| Classification | Monoclonal |
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
|---|---|---|---|---|---|---|---|---|---|
| Product Code | Brand | Quantity | Price | Quantity & Availability | |||||
18773787
![]() |
R&D Systems
MAB14382-SP |
25 μg |
209.00 €
25µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
18750527
![]() |
R&D Systems
MAB14382-100 |
100 μg |
491.00 €
100µg |
Please sign in to purchase this item. Need a web account? Register with us today! | |||||
Description
Parkin Monoclonal specifically detects Parkin in Human samples. It is validated for Immunohistochemistry.Specifications
| Parkin | |
| Immunohistochemistry 5-25 ug/mL | |
| Monoclonal | |
| Purified | |
| RUO | |
| Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose. *Small pack size (SP) is supplied as a 0.2 μm filtered solution in PBS. | |
| AR-JP, E3 ubiquitin ligase, E3 ubiquitin-protein ligase parkin, EC 6.3.2.-, LPRS2, PARK2, parkin, parkin 2, Parkinson disease protein 2, Parkinson juvenile disease protein 2, parkinson protein 2, E3 ubiquitin protein ligase (parkin), PDJ, PDJjuvenile) 2, parkin, PRKN | |
| E. coli-derived recombinant human Parkin, Met1-Val437, Accession # NP_054642 | |
| Primary | |
| Reconstitute at 0.5 mg/mL in sterile PBS. |
| 328110 | |
| Immunohistochemistry | |
| Unconjugated | |
| Mouse | |
| Human | |
| NP_054642 | |
| 5071 | |
| IgG2a | |
| Protein A or G purified from hybridoma culture supernatant | |
| Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70°C as supplied. 1 month, 2 to 8°C under sterile conditions after reconstitution. 6 months, -20 to -70°C under sterile conditions after reconstitution. |
Spot an opportunity for improvement?Share a Content Correction
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title